ClinicalTrials.gov
ClinicalTrials.gov Menu

Toronto Bedside Swallowing Screening Test (TOR-BSST) - A Bedside Swallowing Screening for Stroke Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00141752
Recruitment Status : Completed
First Posted : September 1, 2005
Last Update Posted : November 1, 2016
Sponsor:
Collaborators:
Canadian Stroke Network
Toronto Rehabilitation Institute
Parkwood Hospital, London, Ontario
Sunnybrook Health Sciences Centre
Hamilton Health Sciences Corporation
Information provided by (Responsible Party):
University Health Network, Toronto

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
This research will assess the accuracy of the Toronto Bedside Swallowing Screening Test (TOR-BSST), a new dysphagia screening test for patients with stroke. The purpose of the TOR-BSST is to predict the presence of dysphagia in stroke patients across their continuum of care in a simple and efficient manner. This initial research will assess the accuracy of the TOR-BSST in the acute and rehabilitative settings using videofluoroscopy as the gold standard for comparison. The results from this research will also assess the stability of the TOR-BSST across nursing, its primary user, and generate an estimate for the prevalence of dysphagia in adult stroke patients in the acute and rehabilitative settings. Participants in this research will be 315 stroke patients from several teaching centres in Ontario, namely 105 acute patients from the University Health Network, Sunnybrook & Women's College Health Sciences Centre, and Hamilton General Hospital, and 210 patients in the rehabilitation setting from the Toronto Rehabilitation Institute and Parkwood Hospital, London. Both the TOR-BSST and videofluoroscopic assessment will be administered within 24 hours of each other and interpreted according to published preferred practice guidelines for dysphagia. This research will be the first to implement and assess a standardised method for screening for dysphagia in stroke patients across the continuum of stroke recovery.

Condition or disease Intervention/treatment
Cerebrovascular Accident Deglutition Disorders Device: Toronto Bedside Swallowing Screening Test (TOR-BSST)

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Actual Enrollment : 311 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Toronto Bedside Swallowing Screening Test (TOR-BSST) - A Bedside Swallowing Screening for Stroke Patients
Study Start Date : October 2002
Actual Primary Completion Date : December 2006

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Intervention Details:
  • Device: Toronto Bedside Swallowing Screening Test (TOR-BSST)
    Toronto Bedside Swallowing Screening Test

Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Newly admitted patients with a diagnosis of stroke (refer to eligibility criteria)
Criteria

Inclusion Criteria:

  • patients with a new diagnosis of brainstem or cerebellar stroke
  • patients with a new diagnosis of cortical stroke with NIH Stroke Scale score of 4 or above

Exclusion Criteria:

  • patients with a previous history of stroke with dysphagia
  • patients with a confirmed history of Parkinson's, Parkinsonian Syndrome, ALS, MSA, MS, dementia, or other neurodegenerative disease
  • patients with a history of cranial neurosurgery
  • patients with a known previous or current oropharyngeal dysphagia due to structural or neurological cause
  • patients with active COPD or current pneumonia
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00141752


Locations
Canada, Ontario
Hamilton General Hospital
Hamilton, Ontario, Canada, L8L 2X2
Parkwood Hospital
London, Ontario, Canada, N6C 5J1
Sunnybrook and Women's College Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5
Toronto Rehabilitation Institute
Toronto, Ontario, Canada, M5G 2A2
Toronto Western Hospital, University Health Network
Toronto, Ontario, Canada, M5T 2S8
Sponsors and Collaborators
University Health Network, Toronto
Canadian Stroke Network
Toronto Rehabilitation Institute
Parkwood Hospital, London, Ontario
Sunnybrook Health Sciences Centre
Hamilton Health Sciences Corporation
Investigators
Principal Investigator: Rosemary Martino, PhD University of Toronto
Principal Investigator: Nicholas E Diamant, MD University Health Network, Toronto
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications:

Responsible Party: University Health Network, Toronto
ClinicalTrials.gov Identifier: NCT00141752     History of Changes
Other Study ID Numbers: CSN II.10
First Posted: September 1, 2005    Key Record Dates
Last Update Posted: November 1, 2016
Last Verified: January 2012

Keywords provided by University Health Network, Toronto:
Cerebrovascular Accident
Deglutition Disorders
stroke
dysphagia
screening

Additional relevant MeSH terms:
Stroke
Deglutition Disorders
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
 Cardiovascular Diseases
Esophageal Diseases
Gastrointestinal Diseases
Digestive System Diseases
Pharyngeal Diseases
Otorhinolaryngologic Diseases